JRSIS HEALTH CARE Corp (Form: 8-K, Received: 04/26/2019 13:15:58)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 26, 2019

JRSIS HEALTH CARE CORPORATION

(Exact name of registrant as specified in its charter)

Florida	1-36758	46-4562047
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

1st - 7th Floor, Industrial and Commercial Bank Building

Xingfu Street, Hulan Town, Hulan District, Harbin City

Heilongjiang Province, P.R. China 150025

(Address of Principal Executive Office) (Zip Code)

86-451-56888933

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01

Other Events

On April 26, 2019 the Registrant's Board of Directors issued a press release announcing that it had declared a 20% common stock dividend payable to shareholders of record on May 13, 2019.

Item 9.01

Financial Statements and Exhibits

Exhibits

Press Release dated April 26, 2019

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	JRSIS Health Care Corporation

Date: April 26, 2019	By:	/s/ Lihua Sun
		Lihua Sun, Chief Executive Officer

Exhibit 99.1

Press Release: JRSIS HEATH CARE CORPORATION Declares Dividend on Common Stock

JRSIS HEALTH CARE CORPORATION Declares Dividend on Common Stock

NEW YORK, UNITED STATES, April 26, 2019 -- JRSIS Health Care Corporation (OTCQX: JRSS), a corporation organized in the United States under the laws of the State of Florida, which owns one main hospital and two branches, today announced that its Board of Directors has declared a one-time 20% stock dividend for shareholders of record as of May 13, 2019. Each shareholder will receive 20 shares of stock for every 100 shares owned. The stock dividend will be issued on May 28, 2019.

About JRSIS Health Care Corporation.

JRSIS Health Care Corporation is a corporation organized in the United States under laws of the State of Florida, which owns one main hospital and two branches located in Harbin City in the People's Republic of China. The Company provides well rounded medical services to all of its patients. From less complicated services such as Dentistry to highly sophisticated operations such as General Surgery, the Hospitals' staff are prepared to provide immediate medical treatment services throughout all 24 hours of the day. The modern facilities and cutting-edge equipment, as well as highly skilled and experienced personnel, enable the Hospitals to attend to patient medical and healthcare needs. The Company offer comprehensive healthcare services including: medical consulting, surgery, obstetrics and gynecology, pediatrics, anesthesia, clinic laboratory, medical imaging, and traditional Chinese medicine.

Contact:

2860264901@qq.com